Lancellotti, Patrizio ; Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie ; Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, Italy ; Anthea Hospital, Bari, Italy (P.L.).
Go, Yun Yun; National Heart Research Institute Singapore, National Heart Centre Singapore
Language :
English
Title :
Reduction in Afterload Reveals the Apical Sparing Phenotype.
Aimo A, Merlo M, Porcari A, Georgiopoulos G, Pagura L, Vergaro G, Sinagra G, Emdin M, Rapezzi C,. Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies. Eur J Heart Fail. 2022: 1-10. doi: 10.1002/ejhf.2532
Shah KB, Inoue Y, Mehra MR,. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006; 166: 1805-1813. doi: 10.1001/archinte.166.17.1805
Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C, Wollenweber T, Ahmed N, Thornton GD, Kelion AD,. Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol. 2021; 77: 128-139. doi: 10.1016/j.jacc.2020.11.006
Castaño A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, Rubin J, Chiuzan C, Nazif T, Vahl T,. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J. 2017; 38: 2879-2887. doi: 10.1093/eurheartj/ehx350
Scully PR, Patel KP, Treibel TA, Thornton GD, Hughes RK, Chadalavada S, Katsoulis M, Hartman N, Fontana M, Pugliese F,. Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. Eur Heart J. 2020; 41: 2759-2767. doi: 10.1093/eurheartj/ehaa170
Rosenblum H, Masri A, Narotsky DL, Goldsmith J, Hamid N, Hahn RT, Kodali S, Vahl T, Nazif T, Khalique OK,. Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis. Eur J Heart Fail. 2021; 23: 250-258. doi: 10.1002/ejhf.1974
Singal AK, Bansal R, Singh A, Dorbala S, Sharma G, Gupta K, Saxena A, Bhargava B, Karthikeyan G, Ramakrishnan S,. Concomitant transthyretin amyloidosis and severe aortic stenosis in elderly Indian population: a pilot study. JACC CardioOncol. 2021; 3: 565-576. doi: 10.1016/j.jaccao.2021.08.008
Treibel TA, Fontana M, Gilbertson JA, Castelletti S, White SK, Scully PR, Roberts N, Hutt DF, Rowczenio DM, Whelan CJ,. Occult transthyretin cardiac amyloid in severe calcific aortic stenosis. Circ Cardiovasc Imaging. 2016; 9: 1-10. doi: 10.1161/CIRCIMAGING.116.005066
Cavalcante JL, Rijal S, Abdelkarim I, Althouse AD, Sharbaugh MS, Fridman Y, Soman P, Forman DE, Schindler JT, Gleason TG,. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. J Cardiovasc Magn Reson. 2017; 19: 98. doi: 10.1186/s12968-017-0415-x
Galat A, Guellich A, Bodez D, Slama M, Dijos M, Zeitoun DM, Milleron O, Attias D, Dubois-Randé JL, Mohty D,. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? Eur Heart J. 2016; 37: 3525-3531. doi: 10.1093/eurheartj/ehw033
Java AP, Greason KL, Dispenzieri A, Grogan M, King KS, Maleszewski JJ, Daly RC, Eleid MF, Pochettino A, Schaff HV,. Aortic valve replacement in patients with amyloidosis. J Thorac Cardiovasc Surg. 2018; 156: 98-103. doi: 10.1016/j.jtcvs.2017.12.048
Nitsche C, Koschutnik M, Donà C, Radun R, Mascherbauer K, Kammerlander A, Heitzinger G, Dannenberg V, Spinka G, Halavina K,. Reverse remodeling following valve replacement in coexisting aortic stenosis and transthyretin cardiac amyloidosis. Circ Cardiovasc Imaging. 2022; 15: e014115. doi: 10.1161/CIRCIMAGING.122.014115
Shimoni S, Zikri M, Haberman D, Livschitz S, Tshori S, Fabricant Y, Meledin V, Gandelman G, Goland S, George J,. Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival. ESC Heart Fail. 2021; 8: 4549-4561. doi: 10.1002/ehf2.13667
Audet A, Côté N, Couture C, Bossé Y, Després JP, Pibarot P, Mathieu P,. Amyloid substance within stenotic aortic valves promotes mineralization. Histopathology. 2012; 61: 610-619. doi: 10.1111/j.1365-2559.2012.04265.x
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T,. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018; 379: 1007-1016. doi: 10.1056/nejmoa1805689
Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U,. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021; 42: 1554-1568. doi: 10.1093/eurheartj/ehab072
